- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sandu Pharmaceuticals has announced the closure of its trading window from July 1, 2026. This restriction will remain in effect until 48 hours after the financial results for the quarter ended June 30, 2026, are declared. This measure applies to directors, key management, promoters, and designated persons, preventing trading in company securities to avoid insider trading. The company will announce the board meeting date for approving these results in due course. This signals upcoming quarterly earnings and ensures fair market practices.